Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Aflibercept + FOLFIRI & Colorectal Cancer (CRC), Aflibercept + FOLFIRI is approved by both FDA and EMA for metastatic Colorectal Cancer (CRC) after prior oxaliplatin‑based therapy (1)
(1)
see also:
Angiogenesis inhibitors + Chemotherapy (CT) & Colorectal cancer (CRC)
Colorectal cancer (CRC) & Drugs/Treatments
…